課程資訊
課程名稱
生技製藥二
Pharmaceutical Biotechnology (Ⅱ) 
開課學期
101-1 
授課對象
醫學院  藥學研究所  
授課教師
 
課號
PHARM5007 
課程識別碼
423 U0540 
班次
 
學分
全/半年
半年 
必/選修
選修 
上課時間
星期一6(13:20~14:10) 
上課地點
基1203 
備註
必須同時修習生技製藥一
總人數上限:18人 
Ceiba 課程網頁
http://ceiba.ntu.edu.tw/1011biopharm2 
課程簡介影片
 
核心能力關聯
核心能力與課程規劃關聯圖
課程大綱
為確保您我的權利,請尊重智慧財產權及不得非法影印
課程概述

This is the second part of a half-year survey course aimed to introduce Pharmacy students to various biotechnology-related techniques and their applications in the discovering and manufacturing of biopharmaceuticals as well as biomedical research. The course begins with a general introduction to the physicochemical characteristics, pharmacology, and formulation of proteins and the basics in protein production and manufacturing. Since the production, downstream processing, and characterization of biopharmaceuticals are in many aspects very different from conventional small molecular therapeutics, issues relevant to the handling and delivering of those products are also highlighted. Finally, several approved and potential biopharmaceuticals are discussed. Two hours of lecture per week.
 

課程目標
To introduce Pharmacy students to various biotechnology-related techniques and their applications in the discovering and manufacturing of biopharmaceuticals as well as biomedical research 
課程要求
 
預期每週課後學習時數
 
Office Hours
 
指定閱讀
 
參考書目
References:
1. (CS) D. J.A. Crommelin, R.D. Sindelar (2002), Pharmaceutical Biotechnology — An Introduction for Pharmacists and Pharmaceutical Scientists, Hardwood Academic Publishers
2. (KM) O. Kayser, R.H. Muller (2004), Pharmaceutical Biotechnology — Drug Discovery and Clinical Applications, Wiley-VCH 
評量方式
(僅供參考)
 
No.
項目
百分比
說明
1. 
Written Report/Oral Presentation 
60% 
 
2. 
Written Exams 
30% 
one final 
3. 
Class Participation 
10% 
 
 
課程進度
週次
日期
單元主題
第10週
11/12  Gene Therapy
 
第11週
11/19  Hybridoma Technology & Applications in the Production of Monoclonal Antibodies

 
第12週
11/26  Biotechnologically Derived Therapeutic Proteins: insulin, monoclonal antibodies 
第13週
12/03  Vaccines 
第14週
12/10  Recombinant Thrombolytic Agents, Recombinant Coagulation Factors 
第15週
12/17  Biotechnology Products in the Pipeline 
第16週
12/24  Group Discussion/Presentation 
第17週
12/31  Group Discussion/Presentation